Alves, B.; Peixoto, J.; Macedo, S.; Pinheiro, J.; Carvalho, B.; Soares, P.; Lima, J.; Lima, R.T.
High VEGFA Expression Is Associated with Improved Progression-Free Survival after Bevacizumab Treatment in Recurrent Glioblastoma. Cancers 2023, 15, 2196.
https://doi.org/10.3390/cancers15082196
AMA Style
Alves B, Peixoto J, Macedo S, Pinheiro J, Carvalho B, Soares P, Lima J, Lima RT.
High VEGFA Expression Is Associated with Improved Progression-Free Survival after Bevacizumab Treatment in Recurrent Glioblastoma. Cancers. 2023; 15(8):2196.
https://doi.org/10.3390/cancers15082196
Chicago/Turabian Style
Alves, Bárbara, Joana Peixoto, Sofia Macedo, Jorge Pinheiro, Bruno Carvalho, Paula Soares, Jorge Lima, and Raquel T. Lima.
2023. "High VEGFA Expression Is Associated with Improved Progression-Free Survival after Bevacizumab Treatment in Recurrent Glioblastoma" Cancers 15, no. 8: 2196.
https://doi.org/10.3390/cancers15082196
APA Style
Alves, B., Peixoto, J., Macedo, S., Pinheiro, J., Carvalho, B., Soares, P., Lima, J., & Lima, R. T.
(2023). High VEGFA Expression Is Associated with Improved Progression-Free Survival after Bevacizumab Treatment in Recurrent Glioblastoma. Cancers, 15(8), 2196.
https://doi.org/10.3390/cancers15082196